Abilify User Says Drug Made Him Compulsively Gamble
Law360, New York (January 14, 2016, 4:06 PM EST) -- A consumer on Wednesday hit Bristol-Myers Squibb in New York federal court with a personal injury suit, claiming that he developed a compulsive gambling problem after taking the antipsychotic drug Abilify and that American users weren’t warned about the risk of pathological gambling.
Sean Brazil said that he began taking Abilify in 2004 and shortly thereafter started compulsively gambling, which lasted until he stopped taking the drug a decade later. Even though the drug’s labeling in Europe and Canada warns about the risk of compulsive gambling, Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd. don’t warn or educate Abilify users or...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!